Lifecore Biomedical: The Turnaround Is Just Getting Started

It is easy to look at a chart that has run up ~25% YTD and assume the opportunity has passed. In many cases you would be right, but Lifecore Biomedical ( LFCR ) is currently exitingI'm a fundamental investor who targets situations where the market has pushed a company’s valuation far out of line with its underlying economics. My professional background in corporate financial analysis has deeply shaped my investment perspective, leading me to focus intensely on cash flow durability, balance sheet strength, a ...